Results
|
4041.
|
|
|
4042.
|
|
|
4043.
|
|
|
4044.
|
|
|
4045.
|
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans. [electronic resource] by
- Nanzigu, S
- Eriksen, J
- Makumbi, F
- Lanke, S
- Mahindi, M
- Kiguba, R
- Beck, O
- Ma, Q
- Morse, G D
- Gustafsson, L L
- Waako, P
Producer: 20120425
In:
HIV medicine vol. 13
Availability: No items available.
|
|
4046.
|
|
|
4047.
|
|
|
4048.
|
|
|
4049.
|
Optimization of the antiviral potency and lipophilicity of halogenated 2,6-diarylpyridinamines as a novel class of HIV-1 NNRTIS. [electronic resource] by
- Wu, Zhi-Yuan
- Liu, Na
- Qin, Bingjie
- Huang, Li
- Yu, Fei
- Qian, Keduo
- Morris-Natschke, Susan L
- Jiang, Shibo
- Chen, Chin Ho
- Lee, Kuo-Hsiung
- Xie, Lan
Producer: 20160310
In:
ChemMedChem vol. 9
Availability: No items available.
|
|
4050.
|
|
|
4051.
|
Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. [electronic resource] by
- Wan, Zheng-Yong
- Yao, Jin
- Tao, Yuan
- Mao, Tian-Qi
- Wang, Xin-Long
- Lu, Yi-Pei
- Wang, Hai-Feng
- Yin, Hong
- Wu, Yan
- Chen, Fen-Er
- De Clercq, Erik
- Daelemans, Dirk
- Pannecouque, Christophe
Producer: 20160412
In:
European journal of medicinal chemistry vol. 97
Availability: No items available.
|
|
4052.
|
|
|
4053.
|
Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial. [electronic resource] by
- Gupta, Samir K
- McComsey, Grace A
- Lombaard, John
- Echevarría, Juan
- Orrell, Catherine
- Avihingsanon, Anchalee
- Osiyemi, Olayemi
- Santoscoy, Mario
- Ray, Neelanjana
- Stock, David A
- Joshi, Samit R
- Hanna, George J
- Lataillade, Max
Producer: 20161012
In:
The lancet. HIV vol. 3
Availability: No items available.
|
|
4054.
|
|
|
4055.
|
|
|
4056.
|
|
|
4057.
|
|
|
4058.
|
|
|
4059.
|
|
|
4060.
|
|